1. Home
  2. HEI vs INSM Comparison

HEI vs INSM Comparison

Compare HEI & INSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HEI
  • INSM
  • Stock Information
  • Founded
  • HEI 1957
  • INSM 1988
  • Country
  • HEI United States
  • INSM United States
  • Employees
  • HEI 10000
  • INSM N/A
  • Industry
  • HEI Aerospace
  • INSM Biotechnology: Pharmaceutical Preparations
  • Sector
  • HEI Industrials
  • INSM Health Care
  • Exchange
  • HEI Nasdaq
  • INSM Nasdaq
  • Market Cap
  • HEI 44.2B
  • INSM 40.7B
  • IPO Year
  • HEI N/A
  • INSM 2000
  • Fundamental
  • Price
  • HEI $314.11
  • INSM $193.63
  • Analyst Decision
  • HEI Buy
  • INSM Strong Buy
  • Analyst Count
  • HEI 12
  • INSM 19
  • Target Price
  • HEI $345.36
  • INSM $171.12
  • AVG Volume (30 Days)
  • HEI 280.5K
  • INSM 2.3M
  • Earning Date
  • HEI 12-16-2025
  • INSM 10-30-2025
  • Dividend Yield
  • HEI 0.08%
  • INSM N/A
  • EPS Growth
  • HEI 34.01
  • INSM N/A
  • EPS
  • HEI 4.57
  • INSM N/A
  • Revenue
  • HEI $4,289,298,000.00
  • INSM $447,022,000.00
  • Revenue This Year
  • HEI $16.24
  • INSM $40.09
  • Revenue Next Year
  • HEI $9.79
  • INSM $129.64
  • P/E Ratio
  • HEI $68.63
  • INSM N/A
  • Revenue Growth
  • HEI 13.46
  • INSM 30.34
  • 52 Week Low
  • HEI $216.68
  • INSM $60.40
  • 52 Week High
  • HEI $338.92
  • INSM $197.08
  • Technical
  • Relative Strength Index (RSI)
  • HEI 45.14
  • INSM 69.89
  • Support Level
  • HEI $313.02
  • INSM $182.53
  • Resistance Level
  • HEI $334.33
  • INSM $189.31
  • Average True Range (ATR)
  • HEI 7.78
  • INSM 8.01
  • MACD
  • HEI 0.17
  • INSM 0.32
  • Stochastic Oscillator
  • HEI 16.45
  • INSM 89.27

About HEI Heico Corporation

Heico is an aerospace and defense supplier that focuses on creating replacement parts for commercial aircraft and components for defense products. In commercial aerospace, Heico is the largest independent producer of replacement aircraft parts. In the defense market, the company produces niche subcomponents used in targeting technology as well as simulation equipment, among other categories. It operates as two segments: the flight support group,or FSG, and the electronic technologies group, or ETG, both of which supply the aerospace and defense sectors to different degrees. The company is persistently acquisitive, focusing on companies in similar or adjacent markets that offer strong cash flow and profitable growth potential.

About INSM Insmed Incorporated

Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the United States for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. It is also developing Brensocatib, an oral reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis and other neutrophil-mediated diseases, and Treprostinil Palmitil Inhalation Powder, an inhaled treprostinil prodrug for pulmonary hypertension linked to interstitial lung disease and pulmonary arterial hypertension.

Share on Social Networks: